ES513449A0 - Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona.

Info

Publication number
ES513449A0
ES513449A0 ES513449A ES513449A ES513449A0 ES 513449 A0 ES513449 A0 ES 513449A0 ES 513449 A ES513449 A ES 513449A ES 513449 A ES513449 A ES 513449A ES 513449 A0 ES513449 A0 ES 513449A0
Authority
ES
Spain
Prior art keywords
pirrolidinil
quinolil
piperidil
propanone
ethanone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES513449A
Other languages
English (en)
Other versions
ES8305354A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmindustrie
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of ES8305354A1 publication Critical patent/ES8305354A1/es
Publication of ES513449A0 publication Critical patent/ES513449A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES513449A 1980-06-20 1982-06-25 Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona. Granted ES513449A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8013698A FR2485014A1 (fr) 1980-06-20 1980-06-20 Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments

Publications (2)

Publication Number Publication Date
ES8305354A1 ES8305354A1 (es) 1983-04-01
ES513449A0 true ES513449A0 (es) 1983-04-01

Family

ID=9243305

Family Applications (3)

Application Number Title Priority Date Filing Date
ES503166A Granted ES503166A0 (es) 1980-06-20 1981-06-17 Un procedimiento para la preparacion de nuevos derivados de la 1-(2,-3 o 4-quinolil)2-o-3(2-o 3-(piperidil o pirrolidi- nil) etanona o propanona.
ES513449A Granted ES513449A0 (es) 1980-06-20 1982-06-25 Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona.
ES513448A Expired ES8305353A1 (es) 1980-06-20 1982-06-25 Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES503166A Granted ES503166A0 (es) 1980-06-20 1981-06-17 Un procedimiento para la preparacion de nuevos derivados de la 1-(2,-3 o 4-quinolil)2-o-3(2-o 3-(piperidil o pirrolidi- nil) etanona o propanona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES513448A Expired ES8305353A1 (es) 1980-06-20 1982-06-25 Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona.

Country Status (16)

Country Link
US (1) US4402961A (es)
EP (1) EP0042781B1 (es)
JP (1) JPS57102885A (es)
AR (1) AR227731A1 (es)
AU (1) AU537379B2 (es)
CA (1) CA1184180A (es)
DE (1) DE3169169D1 (es)
DK (1) DK271981A (es)
ES (3) ES503166A0 (es)
FR (1) FR2485014A1 (es)
GR (1) GR75685B (es)
IL (1) IL63125A0 (es)
MA (1) MA19184A1 (es)
NO (1) NO812105L (es)
PT (1) PT73232B (es)
ZA (1) ZA814126B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471981A1 (fr) * 1979-12-21 1981-06-26 Pharmindustrie Nouveaux derives de la (piperidyl-4)-2 (quinolyl-4)-1 ethanone, produits intermediaires et procedes pour leur preparation, et leur utilisation comme medicaments
IL62240A0 (en) * 1980-03-06 1981-05-20 Acf Chemiefarma Nv Novel quinoline derivatives,pharmaceutical compositions containing such compounds,and methods for the preparation of these compounds
GR74482B (es) * 1980-03-06 1984-06-28 Acf Chemiefarma Nv
FR2495470A1 (fr) * 1980-12-05 1982-06-11 Pharmindustrie Nouveaux medicaments a base de derives de (quinolyl-4)-1 (piperidyl-4)-2 ethanol ou (quinolyl-4)-1 (piperidyl-4)-3 propanol
FR2525595A1 (fr) * 1982-04-27 1983-10-28 Pharmuka Lab Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
US4560692A (en) * 1984-07-18 1985-12-24 Hoffmann-La Roche Inc. 4-Piperidino-2-phenylquinolines
FR2582514B1 (fr) * 1985-05-30 1988-02-19 Rhone Poulenc Sante Medicaments a base d'amides, nouveaux amides et leur preparation
FR2664592B1 (fr) * 1990-07-10 1994-09-02 Adir Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5240942A (en) * 1990-07-10 1993-08-31 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
US5493024A (en) * 1991-04-11 1996-02-20 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides
WO2000071519A2 (en) * 1999-05-21 2000-11-30 Eli Lilly And Company Immunopotentiator agents
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
WO2002013825A1 (en) * 2000-08-11 2002-02-21 Smithkline Beecham P.L.C. Novel pharmaceutical use of quinnoline derivatives
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US20040039206A1 (en) * 2001-11-13 2004-02-26 Moher Eric David Process for resolving racemic mixtures of piperidine derivatives
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
US7348434B2 (en) 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2858619B1 (fr) * 2003-08-08 2006-12-22 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
KR20130025860A (ko) * 2009-11-07 2013-03-12 메르크 파텐트 게엠베하 Ｔｇｆ-베타 수용체 키나아제 저해제로서의 헤테로아릴아미노퀴놀린

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR959917A (es) * 1946-06-25 1950-04-07
US3857837A (en) * 1968-07-02 1974-12-31 Hoffmann La Roche Processes and intermediated for quinine, quinidine, isomers and derivatives thereof
GB1441244A (en) * 1972-11-17 1976-06-30 Rech Et Dapplications Scient S Derivatives of quinoline and method of preparing the same
US3953453A (en) * 1973-12-07 1976-04-27 Hoffmann-La Roche Inc. Trifluoromethyl substituted analogs of quinine and quinidine
PT66682B (pt) * 1976-06-18 1978-11-15 Ind Biolog Francaise /(quinolyl-4)-propyl-1/-4 piperidines leur preparation et leur utilisation comme medicaments /(quinolyl-4)-propyl/-4 piperidines leur preparation et leur utilisation comme medicaments
FR2354771A1 (fr) * 1976-06-18 1978-01-13 Mar Pha Etu Expl Marques ((quinolyl-4)-3 propyl-1) -4 piperidines, leur preparation et leur utilisation comme medicaments
FR2381044A1 (fr) * 1977-02-17 1978-09-15 Hoffmann La Roche Procede pour la preparation de mefloquine
GR69926B (es) * 1978-03-23 1982-07-21 Pharmindustrie

Also Published As

Publication number Publication date
ES513448A0 (es) 1983-04-01
FR2485014B1 (es) 1984-05-04
EP0042781B1 (fr) 1985-03-06
IL63125A0 (en) 1981-09-13
MA19184A1 (fr) 1981-12-31
ES8300748A1 (es) 1982-11-01
DE3169169D1 (en) 1985-04-11
ZA814126B (en) 1982-06-30
FR2485014A1 (fr) 1981-12-24
DK271981A (da) 1981-12-21
AR227731A1 (es) 1982-11-30
CA1184180A (fr) 1985-03-19
PT73232B (fr) 1982-07-30
AU7198381A (en) 1981-12-24
GR75685B (es) 1984-08-02
US4402961A (en) 1983-09-06
ES8305354A1 (es) 1983-04-01
PT73232A (fr) 1981-07-01
ES503166A0 (es) 1982-11-01
ES8305353A1 (es) 1983-04-01
NO812105L (no) 1981-12-21
JPS57102885A (en) 1982-06-26
EP0042781A1 (fr) 1981-12-30
AU537379B2 (en) 1984-06-21

Similar Documents

Publication Publication Date Title
ES513449A0 (es) Un procedimiento para la preparacion de nuevos derivados de la 1-(2, -3 o -4-quinolil) 2- o -3-(2- o -3-piperidil o pirrolidinil) etanona o propanona.
ES506661A0 (es) Un procedimiento para la preparacion de nuevos derivados de la sacarosa industrialmente utiles.
ES508286A0 (es) Un procedimiento para la preparacion de derivados de imidazolil-propanol.
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES505922A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES499504A0 (es) Un procedimiento para la preparacion de un derivado de piperazina.
ES537278A0 (es) Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES518518A0 (es) Procedimiento para la fabricacion de nuevos derivados aminoalcoxi aromaticos.
ES509669A0 (es) Un procedimiento para la preparacion de derivados de triazol.
ES501339A0 (es) Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno.
ES501077A0 (es) Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.
ES500251A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1-(4-arilciclohexil)-piperidinas.
ES501432A0 (es) Un procedimiento para la preparacion de 4,5-diaril-&-cpolifluoralquil)-1-4-pirrol-2metanaminas antiinflamatorias.
ES507755A0 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES504793A0 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
ES498208A0 (es) Procedimiento para la obtencion de derivados de triazolilfe-nacil-piridil-eter, de efecto fungicida
ES507482A0 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ES505920A0 (es) Un procedimiento para la preparacion de derivados de isonicotinanilida.
ES504577A0 (es) Un procedimiento para la preparacion de derivados de piridazinona.
ES503338A0 (es) Un procedimiento para la preparacion de derivados de bis-hidroxibencilo.
ES507045A0 (es) Un procedimientpo para la preparacion de nuevos derivados de carbamoiloxiisoxazol.
ES517471A0 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES498743A0 (es) Un procedimiento para la obtencion de nuevos derivados de 2,6-dihalobenzoilo insecticidas.